Pediatric Blood & Cancer · 2020 · 20 citations · 17 references
MedicineHematologyInfectious DiseasesChemotherapyPediatric HematologyPediatric Infectious DiseasesEmpiric Antimicrobial TherapyEmpiric Therapy SelectionPediatric Antibiotic TherapyPediatric Antimicrobial TherapyPediatric ChemotherapyPediatric HematopathologyHematologic AbnormalitiesHuman Monocytic EhrlichiosisPediatric Empiric TherapyPediatric Infection TreatmentRecurrenceSecondary Hemophagocytic Lymphohistiocytosis
We report a large cohort of pediatric patients with human monocytic ehrlichiosis (HME), enabling an estimated incidence of secondary hemophagocytic lymphohistiocytosis (HLH) in hospitalized children with HME. Among 49 children with PCR-confirmed Ehrlichia infection, 8 (16%) met current criteria for HLH. Those with HLH had more significant hematologic abnormalities and longer durations from symptom onset to admission and definitive anti-infective therapy. Among these eight, three received chemotherapy plus doxycycline, one of whom died; the other five were treated with doxycycline without chemotherapy, and all survived without HLH recurrence. Our findings demonstrate that antimicrobial therapy alone can successfully resolve Ehrlichia-associated HLH.
17
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Jan‐Inge Henter, AnnaCarin Horne, Maurizio Aricò et al. · Pediatric Blood & Cancer · 2006 · 5.3K citations
Medicine, Hematology, Immunology +17
Dennis L. Stevens, Alan L. Bisno, Henry F. Chambers et al. · Clinical Infectious Diseases · 2014 · 2.7K citations
Veterinary Medicine, Infectious Diseases, Antimicrobial Pharmacotherapy +15
Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
Iván K. Chinn, Olive S. Eckstein, Erin C. Peckham‐Gregory et al. · Blood · 2018 · 199 citations · Full text
Medicine, Genetics, Pediatrics +14